11.28.05 June 2005: BioVisability Client receives First round Euro Funding Irish-US firm secures €5m in funding Sunday, June 19, 2005 - By Adrian Weckler An Irish-American biotechnology company, which is developing an anti-diarrhoea product, has secured €5 million in first-round funding. Trimed is being backed by Dublin biotech fund Seroba Bioventures and... Read more » 11.28.05 March 2005:BioVisability Sponsors the UC Berkeley Global BioExecutive Program As a continuation of its work with new and emerging bioscience companies, BioVisability, LLC is delighted to announce its sponsorship of Prologue International’s 2nd Annual BioExecutive program. Providing leadership and management training to leaders in the biotechnology industry, the program will... Read more » 11.22.05 Dublin, June 2004: BioVisability Hosts Transatlantic Biotech Event BioVisability Hosts Biotech Event in Ireland with Delegation from San Jose, CA: Dublin’s Sister City Hopes to Attract Irish Companies Expanding to U.S. SOUTH SAN FRANCISCO, CA (PRWEB) July 2, 2004 -- BioVisability, LLC is organizing a program and reception... Read more » 11.22.05 November 16th 2003 Help for biotech firms with eye on US Sunday, November 16, 2003 By Gavin Daly Two Irish biotechnology veterans hope to capitalise on the growing sector with a consulting firm aimed at Irish companies trying to break into the US. David Oliver and... Read more »